Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03477604 · ClinicalTrials.gov registry record · NA

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)

A NA study of Peripheral Arterial Disease, sponsored by Micro Medical Solution.

Active
Registry status
NA
Development phase
177
Enrollment target
20
Study locations

NCT03477604 is a NA study of Peripheral Arterial Disease that is active but no longer recruiting, run by Micro Medical Solution. The registered enrollment target is 177 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03477604, a NA study of Peripheral Arterial Disease, is active but no longer recruiting, sponsored by Micro Medical Solution.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
177 participants
Enrollment target
20
Study locations

Study Summary

Randomized multicenter clinical trial consisting of two arms; one arm treated with PTA plus the MicroStent® System and one arm treated with PTA alone. Purpose to evaluate the safety and effectiveness of using the MicroStent® Peripheral Vascular Stent System, hereafter referred to as the MicroStent® System, for the treatment of infrapopliteal lesions in subjects with peripheral arterial disease.

Conditions Studied

Peripheral Arterial Disease

Interventions

  • DEVICE MicroStent and Standard PTA
  • DEVICE Standard PTA

Study Locations (20)

Florida

  • Palm Vascular - Fort Lauderdale
  • First Coast Cardiovascular Institute - Jacksonville
  • FHV Health - Leesburg
  • Mount Sinai Medical Center - Miami Beach
  • Advent Health Sebring - Sebring

New Jersey

  • Deborah Heart and Lung Center - Browns Mills
  • North Jersey Vascular Center - Clifton
  • AMI Vascular Institute - Galloway

Alabama

  • Cardiovascular Associates of the Southeast - Birmingham

Arizona

  • Copper State Vascular - Mesa

California

  • St. Helena Hospital - St. Helena

Colorado

  • Rocky Mountain Regional VA Medical Center - Aurora

Iowa

  • Vascular Institute of the Midwest - Davenport

Louisiana

  • Cardiovascular Institute of the South - Houma

Trial Details

FieldValue
Enrollment Target 177 participants
Start Date 2020-03-31
Est. Completion 2028-03
Phase NA

Sponsor

Micro Medical Solution

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03477604

The ClinicalTrials.gov registry entry for NCT03477604 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (96% lower). The listed sponsor is Micro Medical Solution, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which MicroStent and Standard PTA is the first listed.

NCT03477604 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Florida, New Jersey, Alabama.

Frequently Asked Questions

What is clinical trial NCT03477604 about?

NCT03477604 is a clinical study titled "A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)". Randomized multicenter clinical trial consisting of two arms; one arm treated with PTA plus the MicroStent® System and one arm treated with PTA alone. Purpose to evaluate the safety and effectiveness of using the MicroStent® Peripheral Vascular Stent System, hereafter referred to as the MicroStent® ...

What is the current status of trial NCT03477604?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 177 participants. The study started on 2020-03-31. Estimated completion is 2028-03.

What conditions does trial NCT03477604 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT03477604?

The interventions under investigation include: MicroStent and Standard PTA (DEVICE), Standard PTA (DEVICE).

Who is sponsoring clinical trial NCT03477604?

This trial is sponsored by Micro Medical Solution, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03477604 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peripheral Arterial Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.